One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Maintenance of genome integrity is a dynamic process involving complex regulation systems. Defects in one or more of these pathways could result in cancer. The most important tumor‐suppressor is the transcription factor p53, and its functional inactivation is frequently observed in many tumor types. The tumor suppressive function of p53 is mainly attributed to its ability to regulate numerous target genes at the transcriptional level. While the mechanism of transcriptional induction by p53 is well characterized, p53‐dependent repression is not understood in detail. Here, we review the manifold mechanisms of p53 as a transcriptional repressor. We classify two different categories of repressed genes based on the underlying mechanism, and novel mechanisms which involve regulation through noncoding RNAs are discussed. The complete elucidation of p53 functions is important for our understanding of its tumor‐suppressor activity and, therefore, represents the key for the development of novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“p53 knockout mice are susceptible to different tumor types [5] and restoration of p53-function leads to the regression of tumors in vivo [6, 7].”
BackgroundA Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · cited 1×
“Interestingly, miRNA-34 induction promotes apoptosis and leads to repression of diverse genes involved in cellcycle progression, apoptosis, DNA repair, and angiogenesis [127].”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · cited 1×
“It involves DNA-binding to the p53 consensus site [8].”
BackgroundTranscriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 1×
“Recent analyses of validated repressor sites demonstrate often longer spacers than activator sites [17].”
BackgroundRestoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“p53 knockout mice are susceptible to different tumor types [5] and restoration of p53-function leads to the regression of tumors in vivo [6, 7].”
BackgroundIs a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
A complex barcode underlies the heterogeneous response of p53 to stress
Murray-Zmijewski, F., Slee, E. A., & Lu, X. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2451 · Cited by 420
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
Mack, D. H., Vartikar, J., Pipas, J. M., & Laimins, L. A. (1993) · Nature · doi:10.1038/363281a0 · Cited by 322
Regulation of the Human hsp70 Promoter by p53
Agoff, S. N., Hou, J., Linzer, D. I., & Wu, B. (1993) · Science · doi:10.1126/science.8418500 · Cited by 292 · cited 1×
“Further transcription factors bound by p53 to induce transcriptional repression are c-myc [66], CBF [67], STAT5 [68], HIF1α, [69], Estrogen Receptor [70] and the hepatic nuclear factors (HNF) 4α1 and 6α [71, 72].”
BackgroundXu, D., Wang, Q., Gruber, A., Björkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., & Pisa, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203890 · Cited by 257
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227
Negative regulation of bcl-2 expression by p53 in hematopoietic cells
Wu, Y.-L., Mehew, J. W., Heckman, C. A., Arcinas, M., & Boxer, L. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204067 · Cited by 221
p53 Regulation of G 2 Checkpoint Is Retinoblastoma Protein Dependent
Flatt, P. M., Tang, L. J., Scatena, C. D., Szak, S. T., & Pietenpol, J. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4210-4223.2000 · Cited by 161
p53-dependent Down-regulation of Telomerase Is Mediated by p21
Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133
Spurgers, K. B., Gold, D. L., Coombes, K. R., Bohnenstiehl, N. L., Mullins, B., Meyn, R. E., Logothetis, C. J., & McDonnell, T. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513901200 · Cited by 114 · cited 3×
“Results of another study suggest, that p53-induced repression plays a decisive role in cell-cycle control, as nearly half of repressed p53 targets are cellcycle related [121].”
BackgroundZaky, A., Busso, C., Izumi, T., Chattopadhyay, R., Bassiouny, A., Mitra, S., & Bhakat, K. K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1173 · Cited by 111 · cited 1×
“A recent study demonstrated that endogenous p53 is bound to the APE1 promoter region that includes a SP1 site, and that this binding of p53 interferes with SP1 binding to the APE1 promoter [28].”
Backgroundp130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53
Taylor, W. R., Schönthal, A. H., Galante, J., & Stark, G. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005101200 · Cited by 110 · cited 3×
“fact was demonstrated for survivin [39], hTERT [108], Cdc2 [103, 104, 113], Cyclin A [114] and also suggested for Cyclin B1 [103, 104].”
BackgroundJackson, J. G., & Pereira-Smith, O. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2501-2510.2006 · Cited by 108 · cited 1×
“In addition to these G2/M genes participation of E2Fs and pocket proteins, especially p130, in DNA damage-induced inhibition of several other cell-cycle regulators is described [109, 113, 118, 119] suggesting that this mechanism is another widespread mode of p53-dependent repression.”
BackgroundJackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92 · cited 2×
“In addition to these G2/M genes participation of E2Fs and pocket proteins, especially p130, in DNA damage-induced inhibition of several other cell-cycle regulators is described [109, 113, 118, 119] suggesting that this mechanism is another widespread mode of p53-dependent repression.”
BackgroundBöhlig, L., Friedrich, M., & Engeland, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq796 · Cited by 85
Self-citationB-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
Research works printed but not linked: 138
- 10.1007/978-1-4419-6199-0_5 · DOI
- 10.1038/278261a0 · DOI · Paper page
- 10.1016/0092-8674(79)90293-9 · DOI · Paper page
- 10.1038/35042675 · DOI · Paper page
- 10.1038/356215a0 · DOI · Paper page
- 10.1128/MCB.16.8.4295 · DOI · Paper page
- 10.1128/MCB.13.6.3291 · DOI · Paper page
- 10.1073/pnas.92.11.5154 · DOI · Paper page
- 10.1016/0092-8674(95)90412-3 · DOI · Paper page
- 10.1016/0092-8674(93)90500-P · DOI · Paper page
- 10.1038/sj.cdd.4401191 · DOI · Paper page
- 10.1128/MCB.21.4.1297-1310.2001 · DOI · Paper page
- 10.1016/j.bbcan.2009.12.001 · DOI
- 10.1073/pnas.0903284106 · DOI · Paper page
- 10.1074/jbc.C100121200 · DOI · Paper page
- 10.1016/j.cell.2008.06.006 · DOI · Paper page
- 10.1074/jbc.M304543200 · DOI
- 10.1128/MCB.19.2.1279 · DOI · Paper page
- 10.1128/MCB.01442-07 · DOI · Paper page
- 10.1016/j.bbagrm.2010.04.001 · DOI
- 10.1016/j.febslet.2004.12.073 · DOI · Paper page
- 10.1016/j.molcel.2004.11.002 · DOI · Paper page
- 10.1128/MCB.25.9.3737-3751.2005 · DOI · Paper page
- 10.1006/bbrc.2001.5040 · DOI
- 10.1074/jbc.M006052200 · DOI · Paper page
- 10.1074/jbc.M507712200 · DOI
- 10.1074/jbc.M603724200 · DOI · Paper page
- Bargonetti J., 1997, p53 represses Sp1 DNA binding and HIV-LTR directed transcription, Cellular and Molecular Biology, 43, 935
- 10.1074/jbc.M106643200 · DOI · Paper page
- 10.1093/carcin/bgm219 · DOI · Paper page
- 10.1074/jbc.M404496200 · DOI · Paper page
- 10.1073/pnas.0509313103 · DOI · Paper page
- 10.1038/onc.2009.62 · DOI
- 10.1074/jbc.M007155200 · DOI
- 10.1074/jbc.M311912200 · DOI · Paper page
- 10.1038/sj.onc.1208114 · DOI
- 10.1038/sj.embor.7400587 · DOI · Paper page
- 10.4161/cc.5.10.2764 · DOI
- 10.1016/j.bbrc.2008.02.047 · DOI
- 10.1016/j.abb.2008.10.024 · DOI
- 10.1016/j.jhep.2008.10.025 · DOI
- Webster N. J. G., 1996, Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer, Cancer Research, 56, 2781
- 10.1210/en.139.3.1101 · doi:10.1210/en.139.3.1101 · Paper page
- Zhang L., 2000, Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression, Cancer Research, 60, 3655
- 10.1016/j.mce.2004.05.005 · DOI
- 10.1074/jbc.274.17.11535 · DOI · Paper page
- 10.1002/jcb.20044 · DOI
- 10.1093/nar/28.22.4410 · DOI · Paper page
- 10.1038/sj.onc.1204748 · DOI
- 10.1038/335251a0 · DOI · Paper page
- 10.1074/jbc.274.42.29677 · DOI · Paper page
- 10.1074/jbc.M403232200 · DOI · Paper page
- 10.1074/jbc.M203793200 · DOI
- 10.1124/mol.63.2.359 · DOI
- 10.1128/MCB.17.1.389 · DOI · Paper page
- 10.1016/j.bbrc.2005.08.026 · DOI
- 10.1016/S0303-7207(98)00140-3 · DOI
- 10.1074/jbc.273.20.11995 · DOI · Paper page
- 10.1006/bbrc.1997.7522 · doi:10.1006/bbrc.1997.7522
- 10.1210/me.16.2.402 · doi:10.1210/me.16.2.402
- 10.1042/BJ20060614 · DOI · Paper page
- 10.1128/MCB.15.1.227 · DOI · Paper page
- 10.1073/pnas.89.24.12028 · DOI · Paper page
- 10.1016/S0021-9258(18)53769-8 · DOI · Paper page
- 10.1515/BC.2008.039 · DOI
- 10.1074/jbc.274.16.10911 · DOI · Paper page
- Ragimov N., 1993, Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif, Oncogene, 8, 1183
- 10.1093/emboj/cdg265 · DOI
- 10.1093/nar/24.21.4281 · DOI · Paper page
- 10.1128/MCB.25.8.3247-3260.2005 · DOI
- 10.1101/gad.7.8.1535 · DOI
- 10.1038/sj.onc.1205353 · DOI · Paper page
- 10.1038/sj.onc.1205001 · DOI
- 10.1128/MCB.25.17.7423-7431.2005 · DOI · Paper page
- 10.1074/jbc.C100381200 · DOI · Paper page
- 10.1074/jbc.M504655200 · DOI
- 10.1128/MCB.25.6.2147-2157.2005 · DOI · Paper page
- 10.1128/MCB.25.3.1200-1212.2005 · DOI · Paper page
- 10.1101/gad.13.19.2490 · DOI · Paper page
- 10.1101/gad.10.23.2971 · DOI · Paper page
- 10.1593/neo.04325 · DOI
- 10.1074/jbc.M307185200 · DOI · Paper page
- 10.1073/pnas.0407729102 · DOI · Paper page
- 10.1038/sj.onc.1207464 · DOI
- 10.1038/sj.onc.1202676 · DOI · Paper page
- 10.1073/pnas.88.22.9979 · DOI · Paper page
- 10.1128/MCB.23.13.4713-4727.2003 · DOI · Paper page
- 10.1128/MCB.21.4.1066-1076.2001 · DOI · Paper page
- 10.4161/cc.1.1.101 · DOI · Paper page
- De Toledo S. M., 1998, Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, Thymidine Kinace, Topoisomerase IIα, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21(Waf1), Cell Growth and Differentiation, 9, 887
- 10.1038/sj.onc.1209989 · DOI
- 10.1074/jbc.M602492200 · DOI · Paper page
- 10.1038/sj.onc.1210898 · DOI
- 10.1016/0092-8674(93)90499-G · DOI · Paper page
- 10.1101/gad.6.2.177 · DOI · Paper page
- Spitkovsky D., 1997, Down-regulation of Cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter, Cell Growth and Differentiation, 8, 699
- 10.1111/j.1742-4658.2009.07508.x · DOI · Paper page
- 10.1038/sj.onc.1210799 · DOI · Paper page
- 10.1093/nar/gkp110 · DOI · Paper page
- 10.1074/jbc.M210327200 · DOI · Paper page
- 10.1128/MCB.23.21.7719-7731.2003 · DOI · Paper page
- 10.1016/j.molcel.2009.01.028 · DOI · Paper page
- 10.1038/ncb1770 · DOI · Paper page
- 10.1016/j.cub.2007.06.068 · DOI · Paper page
- 10.1038/nature05939 · DOI · Paper page
- 10.4161/cc.6.13.4436 · DOI · Paper page
- 10.1016/j.molcel.2007.05.017 · DOI · Paper page
- 10.1016/S0092-8674(04)00045-5 · DOI
- 10.1016/j.cell.2007.12.024 · DOI · Paper page
- 10.1038/nature07242 · DOI · Paper page
- 10.1038/nature07228 · DOI · Paper page
- 10.1038/nature09267 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-1569 · DOI · Paper page
- 10.1158/0008-5472.CAN-08-1846 · DOI · Paper page
- 10.1371/journal.pone.0006677 · DOI · Paper page
- 10.1073/pnas.0911082107 · DOI · Paper page
- 10.1038/msb.2008.65 · DOI · Paper page
- 10.1073/pnas.0808042106 · DOI · Paper page
- 10.1038/emboj.2009.214 · DOI · Paper page
- 10.1038/nature07672 · DOI · Paper page
- 10.1073/pnas.0904715106 · DOI · Paper page
- 10.4161/cc.9.5.10825 · DOI · Paper page
- 10.1158/0008-5472.CAN-06-2323 · DOI · Paper page
- 10.1089/jir.1996.16.595 · DOI
- 10.1073/pnas.88.17.7605 · DOI · Paper page
- 10.1038/sj.onc.1202986 · DOI
- 10.1073/pnas.88.5.1958 · DOI · Paper page
- Harris L. C., 1996, Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene, Cancer Research, 56, 2029
- Iotsova V., 1996, TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53, Oncogene, 13, 2331
- 10.4161/cc.6.7.4017 · DOI
- 10.1016/j.febslet.2007.02.028 · DOI
- 10.1128/MCB.20.20.7450-7459.2000 · DOI · Paper page
- 10.1074/jbc.M003338200 · DOI · Paper page
- 10.1101/gad.973602 · DOI · Paper page
- 10.1038/sj.onc.1208380 · DOI
- 10.4161/cbt.2.4.430 · DOI
- 10.1158/0008-5472.CAN-05-1132 · DOI
- 10.4161/cc.7.21.7014 · DOI · Paper page
Cited by
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Cell cycle regulation: p53-p21-RB signaling
Engeland, K. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00988-z · Cited by 1,274
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM
Engeland, K. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.172 · Cited by 656
Understanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
Metadata
- Authors
- Böhlig, L., & Rother, K.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 2011
- Issue
- 1
- Pages
- 464916-464916
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2013269086
- Cited by
- 58
- References
- 24
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Funders
- University of Leipzig
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.